Albert David Ltd. Share Price & Stock Analysis

Albert David Ltd. (BSE: 524075) is a Kolkata, West Bengal-based company in the Pharmaceuticals industry. With a market capitalisation of ₹451 Cr, it ranks #2,068 by market cap among the 6,197 Indian listed companies on FinBizNet, and #28 of 63 in Pharmaceuticals. At ₹782.10 (as of 16 Nov 2026), the share price is 16.1% below its 52-week high of ₹931.85 and 34.9% above its 52-week low of ₹579.90. The share price is down 9.9% over one year and down 2.1% over three months.

Key Metrics

Current Price₹782.10
Market Cap₹451 Cr
BSE Code524075
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E RatioNot meaningful (loss)
Return on Equity-0.38%
Return on Assets-0.49%
52-Week Range₹579.90 – ₹931.85
1-Year Price Change-9.9%
3-Month Price Change-2.1%
Beta (1Y)0.63
Dividend Yield0.63%
HeadquartersKolkata, West Bengal
Websitewww.albertdavidindia.com

Latest Quarterly Results — Q2 FY27

Revenue₹101 Cr
Net Profit₹3 Cr
Net Margin2.9%
EPS (Basic)₹5.05
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Albert David Ltd. Quarterly Revenue and Profit Trend

Albert David Ltd. reported revenue of ₹101 Cr in Q2 FY27, up 15.6% from ₹87 Cr in Q2 FY26 and down 0.5% from ₹101 Cr in Q1 FY27. It posted a net profit of ₹3 Cr for the quarter, against a net loss of ₹3 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹71 Cr (Q1 FY26) to ₹101 Cr (Q1 FY27). The company reported a net loss in 3 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹101 Cr₹3 Cr2.9%
Q1 FY27₹101 Cr₹32 Cr31.6%
Q4 FY26₹86 Cr−₹21 Cr−25.0%
Q3 FY26₹90 Cr₹15 Cr17.0%
Q2 FY26₹87 Cr−₹3 Cr−3.8%
Q1 FY26₹71 Cr₹8 Cr11.3%
Q4 FY25₹75 Cr−₹10 Cr−13.8%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 62.24% of Albert David Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 64.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Albert David Ltd.

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

Products and Services

1. Pharmaceuticals-This segment manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs.

Business Segments

1. Manufacturing of Pharmaceutical Products-100%

Albert David Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Albert David Ltd.₹451 Crn/m-0.38%₹101 Cr-9.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Albert David Ltd.?

Albert David Ltd. is trading at ₹782.10, with a market capitalisation of ₹451 Cr.

Which sector does Albert David Ltd. belong to?

Albert David Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Albert David Ltd.?

Albert David Ltd. has a return on equity of -0.38%.

What is the stock symbol of Albert David Ltd.?

Albert David Ltd. is listed on the BSE under the scrip code 524075.

How has Albert David Ltd.'s share price moved over the past year?

Albert David Ltd.'s share price is down 9.9% over one year and down 2.1% over three months. Its 52-week range is ₹579.90 to ₹931.85.

What were Albert David Ltd.'s latest quarterly results?

In Q2 FY27, Albert David Ltd. reported revenue of ₹101 Cr and net profit of ₹3 Cr, with basic EPS of ₹5.05 (standalone, parsed from the company's exchange filing).

How have Albert David Ltd.'s revenue and profit changed over the past year?

Albert David Ltd. reported revenue of ₹101 Cr in Q2 FY27, up 15.6% from ₹87 Cr in Q2 FY26 and down 0.5% from ₹101 Cr in Q1 FY27.

What is the promoter holding in Albert David Ltd.?

Promoters held 62.24% of Albert David Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.